Atlas FDA

IMMULITE 2500 OM-MA, MODEL L5KOP

FDA 510(k) clearance K072794 · decided 2007-11-05

Clearance details

K-number
K072794
Device name
IMMULITE 2500 OM-MA, MODEL L5KOP
Applicant
Siemens Medical Solutions Diagnostics
Decision
Substantially Equivalent
Date received
2007-10-01
Decision date
2007-11-05
Days to decision
35 days
Clearance type
Special
Product code
LTK
Device class
2
Regulation number
866.6010
Medical specialty
Immunology
Advisory committee
Immunology
Location
Los Angeles, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Siemens Medical Solutions Diagnostics

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Access OV Monitor (K240479)Beckman Coulter, Inc.2024-05-10
IMMULITE/IMMULITE 1000 OM-MA, IMMULITE 2000 OM-MA (K213510)Siemens Healthcare Diagnostics Products, Ltd.2023-09-08
VITROS Immuodiagnostic Products CA 125 II Reagent Pack (K221355)Ortho Clinical Diagnostics2022-12-12
ADVIA Centaur CA 125II (K200199)Siemens Healthcare Diagnostics, Inc.2020-04-06
Elecsys CA-125 II assay (K143534)Roche Professional Diagnostics2015-08-06
LUMIPULSE G1200 System, LUMIPULSE G CA 125II Immunoreaction Cartridges, LUMIPULSE G CA 125II Calibrators (K142895)Fujirebio Diagnostics,Inc.2015-05-21
DIMENSION VISTA LOCI CA 125 FLEX REAGENT CARTRIDGE,AND DIMENSIONS VISTA LOCI 6 CAL, MODEL#'S K6455, AND KC604 (K100321)Siemens Healthcare Diagnostics2011-04-12
VIDAS CA 15-3 ASSAY (K080469)bioMerieux, Inc.2009-06-22
VIDAS CA 125 II ASSAY (K080561)bioMerieux, Inc.2009-04-10
ARCHITECT CA 125 II ASSAY (K042731)Fujirebio Diagnostics,Inc.2004-11-19
ACCESS OV MONITOR ASSAY (K031297)Beckman Coulter, Inc.2003-05-02
ACCESS OV MONITOR IMMUNOENZYMETRIC ASSAY (K023597)Beckman Coulter, Inc.2002-12-11

Recalls involving this device

No recalls on record reference this clearance.